2024 Q3 Form 10-Q Financial Statement

#000182912625000187 Filed on January 15, 2025

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$174.6K
YoY Change -43.63%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $205.7K
YoY Change -51.85%
Income Tax $74.19K
% Of Pretax Income 36.08%
Net Earnings $131.5K
YoY Change -52.76%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $126.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $52.57K
Receivables
Other Receivables
Total Short-Term Assets $178.6K
YoY Change 41.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $29.56M
YoY Change -48.42%
TOTAL ASSETS
Total Short-Term Assets $178.6K
Total Long-Term Assets $29.56M
Total Assets $29.73M
YoY Change -48.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.147M
YoY Change 242.55%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.147M
Total Long-Term Liabilities
Total Liabilities $5.045M
YoY Change 79.14%
SHAREHOLDERS EQUITY
Retained Earnings -$4.849M
YoY Change -810.62%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.849M
YoY Change
Total Liabilities & Shareholders Equity $29.73M
YoY Change -48.22%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $131.5K
YoY Change -52.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001936255
CY2023Q4 FORL Excise Tax Payable Current
ExciseTaxPayableCurrent
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 FORL Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
usd
CY2023Q3 FORL Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
usd
FORL Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
usd
CY2024Q2 FORL Temporary Equity Stock Redeemed During The Period Value
TemporaryEquityStockRedeemedDuringThePeriodValue
usd
CY2023Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
FORL Loss On Change In Fair Value Of Overallotment Option
LossOnChangeInFairValueOfOverallotmentOption
usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
usd
FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
usd
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
FORL Proceeds From Issuance Of Common Stocks
ProceedsFromIssuanceOfCommonStocks
usd
FORL Proceeds From Issuance Of Warrant
ProceedsFromIssuanceOfWarrant
usd
FORL Payment Of Offering Costs On Public Units
PaymentOfOfferingCostsOnPublicUnits
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
FORL Deferred Underwriting Commissions
DeferredUnderwritingCommissions
usd
FORL Issuance Of Representative Shares For Services
IssuanceOfRepresentativeSharesForServices
usd
FORL Directors And Officers Insurance Fee Paid By Potential Target
DirectorsAndOfficersInsuranceFeePaidByPotentialTarget
usd
FORL Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
usd
FORL Excise Tax Liability
ExciseTaxLiability
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 us-gaap Assets
Assets
58124201 usd
CY2024Q3 FORL Accruedofferingcostscurrent
Accruedofferingcostscurrent
24999 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3366873 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
29538303 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
56067420 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4848700 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1310233 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4848559 usd
dei Entity Registrant Name
EntityRegistrantName
Four Leaf Acquisition Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-41646
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1178935
dei Entity Address Address Line1
EntityAddressAddressLine1
4546 El Camino Real B10 #715
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Altos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94022
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
720-5626
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash
Cash
125986 usd
CY2023Q4 us-gaap Cash
Cash
10622 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
52568 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
49842 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
178554 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
60464 usd
CY2024Q3 FORL Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
29555985 usd
CY2023Q4 FORL Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
58063737 usd
CY2024Q3 us-gaap Assets
Assets
29734539 usd
CY2023Q4 FORL Accruedofferingcostscurrent
Accruedofferingcostscurrent
97440 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
403217 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
402663 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
152180 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62180 usd
CY2024Q3 FORL Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
1800100 usd
CY2023Q4 FORL Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
272000 usd
CY2024Q3 FORL Deferred Credit Insurance Fee Current
DeferredCreditInsuranceFeeCurrent
191250 usd
CY2023Q4 FORL Deferred Credit Insurance Fee Current
DeferredCreditInsuranceFeeCurrent
191250 usd
CY2024Q3 FORL Excise Tax Payable Current
ExciseTaxPayableCurrent
301944 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
273755 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
443990 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3147445 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1469523 usd
CY2024Q3 FORL Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
1897350 usd
CY2023Q4 FORL Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
1897350 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5044795 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-42784 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1310092 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29734539 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58124201 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
174608 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
309757 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4636963 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1051053 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
621276 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-174608 usd
CY2023Q2 FORL Accretion Of Class Common Stock To Redemption Value
AccretionOfClassCommonStockToRedemptionValue
-2231134 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-309757 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1051053 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-621276 usd
CY2024Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
380258 usd
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
736855 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1875533 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1465180 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
453111 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2858940 usd
FORL Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
134583 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
205650 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427098 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
824480 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
978487 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74193 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148797 usd
CY2023Q3 FORL Accretion Of Class Common Stock To Redemption Value
AccretionOfClassCommonStockToRedemptionValue
-2286711 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395765 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
278301 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
850530 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
289859 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
131457 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
278301 usd
us-gaap Net Income Loss
NetIncomeLoss
428715 usd
us-gaap Net Income Loss
NetIncomeLoss
688628 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1310092 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
428715 usd
CY2024Q1 FORL Accretion Of Class Common Stock To Redemption Value
AccretionOfClassCommonStockToRedemptionValue
-1439127 usd
CY2024Q1 FORL Accretion Of Class Common Stock To Redemption Value Due To Dividend And Interest Income Earned
AccretionOfClassCommonStockToRedemptionValueDueToDividendAndInterestIncomeEarned
-552520 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
688628 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1875533 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1465180 usd
FORL Loss On Change In Fair Value Of Overallotment Option
LossOnChangeInFairValueOfOverallotmentOption
134583 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2726 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
26172 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-71886 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
316704 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
90000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
35000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-170235 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
289859 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1601665 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-295744 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
55836300 usd
FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
842100 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
542100 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
130602 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3713237 usd
CY2024Q2 FORL Accretion Of Class Common Stock To Redemption Value Due To Dividend And Interest Income Earned
AccretionOfClassCommonStockToRedemptionValueDueToDividendAndInterestIncomeEarned
-554423 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
75000 usd
CY2024Q2 FORL Stockholders Equity Adjustment Excise Tax Payable
StockholdersEquityAdjustmentExciseTaxPayable
-301943 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
166656 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4477947 usd
CY2024Q3 FORL Accretion Of Class Common Stock To Redemption Value Due To Dividend And Interest Income Earned
AccretionOfClassCommonStockToRedemptionValueDueToDividendAndInterestIncomeEarned
-277069 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
225000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
131457 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4848559 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18694 usd
CY2023Q1 FORL Issuance Of Private Placement Warrants
IssuanceOfPrivatePlacementWarrants
3577000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1127840 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270520 usd
CY2023Q1 FORL Accretion Of Class Common Stock To Redemption Value
AccretionOfClassCommonStockToRedemptionValue
-314307 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
31225385 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30383285 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55836300 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1528100 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
95000 usd
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
30194356 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
84000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
395500 usd
FORL Proceeds From Issuance Of Common Stocks
ProceedsFromIssuanceOfCommonStocks
54210000 usd
FORL Proceeds From Issuance Of Warrant
ProceedsFromIssuanceOfWarrant
3577000 usd
FORL Payment Of Offering Costs On Public Units
PaymentOfOfferingCostsOnPublicUnits
1435184 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28666256 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56135316 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
115364 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3272 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10622 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1280 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125986 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4552 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
566000 usd
FORL Accretion Of Class Common Stock Subject To Possible Redemption
AccretionOfClassCommonStockSubjectToPossibleRedemption
3665239 usd
FORL Accretion Of Class Common Stock Subject To Possible Redemption
AccretionOfClassCommonStockSubjectToPossibleRedemption
4832152 usd
FORL Deferred Underwriting Commissions
DeferredUnderwritingCommissions
1897350 usd
FORL Issuance Of Representative Shares For Services
IssuanceOfRepresentativeSharesForServices
270520 usd
FORL Directors And Officers Insurance Fee Paid By Potential Target
DirectorsAndOfficersInsuranceFeePaidByPotentialTarget
191250 usd
FORL Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
97440 usd
FORL Excise Tax Liability
ExciseTaxLiability
301944 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54210000 usd
CY2023Q1 FORL Transaction Costs
TransactionCosts
4019087 usd
CY2023Q1 FORL Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
2710500 usd
CY2023Q1 FORL Payment Of Deferred Underwriting Fees
PaymentOfDeferredUnderwritingFees
813150 usd
CY2023Q1 FORL Other Offering Costs
OtherOfferingCosts
1038067 usd
CY2023Q1 us-gaap Cash
Cash
974028 usd
CY2023Q1 FORL Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2024Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001 usd
CY2024Q3 FORL Percentage Of Shares Sold In Ipo That Can Be Transferred Without Any Restriction
PercentageOfSharesSoldInIpoThatCanBeTransferredWithoutAnyRestriction
0.15 pure
CY2024Q3 FORL Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1 pure
CY2024Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
542100 usd
CY2024Q2 FORL Number Of Months By Which Time Limit Could Be Extended For Consummating Business Combination
NumberOfMonthsByWhichTimeLimitCouldBeExtendedForConsummatingBusinessCombination
P12M
CY2024Q2 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
30200000 usd
CY2024Q2 FORL Per Share Withdrawn From The Trust Account
PerShareWithdrawnFromTheTrustAccount
10.97
CY2024Q2 FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
75000 usd
CY2024Q3 FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
75000 usd
CY2024Q3 FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
75000 usd
CY2024Q3 FORL Extension Payments Deposited Into Trust Account
ExtensionPaymentsDepositedIntoTrustAccount
75000 usd
CY2024Q3 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000 usd
CY2024Q3 FORL Amount Per Share To Be Maintained In The Trust Account
AmountPerShareToBeMaintainedInTheTrustAccount
10.30
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001 usd
CY2024Q3 us-gaap Cash
Cash
125986 usd
CY2024Q3 FORL Accrued Excise Tax Liability
AccruedExciseTaxLiability
0 usd
FORL Accrued Excise Tax Liability
AccruedExciseTaxLiability
301944 usd
CY2024Q3 FORL Excises Tax Liability
ExcisesTaxLiability
301944 usd
CY2023Q4 FORL Excises Tax Liability
ExcisesTaxLiability
0 usd
CY2024Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
464229 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1031029 usd
FORL Payments Of General Operating Expenses
PaymentsOfGeneralOperatingExpenses
110268 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zO0s2L9y5rT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zozw6zgp2qi5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Significant assumptions include the fair value of the Company’s Public Warrants and Representative Shares, at their issuance dates, the valuation of the over-allotment option provided to the underwriters and the excise tax liability in connection with redemption of Class A common stock that occurred at the 2024 Special Meeting. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zaGr44ELGVse" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_861_z06cuz5sCLtg">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20240930_z6D14CaWWW3k" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Share Price
SharePrice
0.81
CY2024Q3 FORL Aggregate Grant Date Fair Value Of The Awards
AggregateGrantDateFairValueOfTheAwards
40500 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
40500 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.348 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.453 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.296 pure
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.453 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.348 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.296 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
22012 usd
CY2024Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
dei Amendment Flag
AmendmentFlag
false

Files In Submission

Name View Source Status
0001829126-25-000187-index-headers.html Edgar Link pending
0001829126-25-000187-index.html Edgar Link pending
0001829126-25-000187.txt Edgar Link pending
0001829126-25-000187-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
forl-20240930.xsd Edgar Link pending
forl-20240930_lab.xml Edgar Link unprocessable
fourleaf_10q.htm Edgar Link pending
fourleaf_ex10-1.htm Edgar Link pending
fourleaf_ex10-2.htm Edgar Link pending
fourleaf_ex10-3.htm Edgar Link pending
fourleaf_ex10-4.htm Edgar Link pending
fourleaf_ex10-5.htm Edgar Link pending
fourleaf_ex10-6.htm Edgar Link pending
fourleaf_ex10-7.htm Edgar Link pending
fourleaf_ex31-1.htm Edgar Link pending
fourleaf_ex31-2.htm Edgar Link pending
fourleaf_ex32-1.htm Edgar Link pending
fourleaf_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
forl-20240930_def.xml Edgar Link unprocessable
forl-20240930_pre.xml Edgar Link unprocessable
forl-20240930_cal.xml Edgar Link unprocessable
fourleaf_10q_htm.xml Edgar Link completed